FDA Investigator Gulshan R Anand
Gulshan R Anand has conducted inspections on 458 sites in 2 countries as of 08 Dec 2021. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
458
Last Inspection Date:
08 Dec 2021
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India
FDA Investigators that have inspected at least one site in common with Gulshan R Anand:
Adam S Freeman,
Adrienne Morgan,
Alanna L Mussawwir Bias,
Alex G Kalugin,
Alexandra B Pitkin,
Alla Dubrovsky,
Allen F Hall,
Amanda E Lewin, PhD,
Andrew E Kay,
Angel K Sandhu,
Angela D Wise,
Anna J Vickrey,
Anna L Marroquin,
Anna L Viveros Hernandez,
Anthony E Guzman,
Arindam Dasgupta, PhD,
Barbara A Rusin,
Barbara J Rincon,
Barbara M Frazier,
Breena L D'ambrogi,
Brian R Yaun,
Burnsb,
Carla J Lundi,
Carol S Sanchez,
Carrie E Thrasher,
Cassandra L Abellard,
Cathleen A Carr Sharpe,
Cathryn M Groehnert,
Celena Ngo,
Christine M Parmentier,
Christopher J Lee,
Courtney N Long,
Craig A Garmendia,
Damon A Growl,
Daniel J Lahar,
Daniel Velasquez,
Darrin E Davis,
David A Laplante,
David Y Hernandez,
Davis,
Dawn C Olenjack,
Deborah A Greco,
Debra J Fracassa,
Dena L Jacobs,
Dr. Sriram Subramaniam, PhD,
Dustin P Tran,
Edna J Hidalgo,
Elizabeth C Ajuzie,
Ellen N Stewart,
Elodie X Tong Lin,
Elva M Ibarra,
Emmanuel O Kerry,
Eric W Anderson,
Erica L Nicoll,
Estefania Fernandez,
Farhana Khan,
Frank P Bianco,
Gajendiran Mahadevan, PhD,
Garciam,
Geoffrey K Kilili,
Gillenwater,
Grant L Davis,
Hector Jcolon Torres,
Helen J Hamaoka,
Henry E Carrillo,
Herbert E Arden,
Herminio C Francisco,
Humberto Z Gomez,
Hyojong Kwon, PhD,
Ingrid A Zambrana,
Ismael Garibay,
Jacqueline O Snell,
James A Barreto,
James C Yee,
James R Fleckenstein,
Jane G Choi,
Janice K Gardner,
Jazmine M Welcher,
Jeannie Pradyanata,
Jeff M Uriarte,
Jeffrey W Shrifter, DPM,
Joanne M Fukuda,
Joanne M Schlossin,
Jocelyn T Ramos,
Johannes S Corley,
John A Gonzalez,
John A Kadavil, PhD,
John A Liu,
John R Myung,
Jonathan K Dare,
Jonathan M Mcbride,
Jorge L Bertran,
Joseph A Seitz, III,
Joseph C Francisco,
Joseph H Lam,
Joseph M Willems,
Joseph R Haynes,
Joseph Tibay,
Joshua C Schafer,
Jude C Dikes,
Judy C Nepsa,
Julia Ventura,
Juliane Kjung Lau,
Ka L Wong,
Kacie M Crowther,
Kaitlyn R Kornberg,
Kara A Scheibner, PhD,
Karen J Bak,
Karen L Robles,
Karen M Willis,
Karl D Hezel,
Karla J Gibler,
Katie T Duong,
Kelvin X Sanders,
Kevin T Gerrity,
Kimberly L Anderson,
Kimberly L Pruszko,
Kimberly M Lichter,
Kip J Hanks,
Kirtida Patel,
Lam,
Lance Mde Souza, MBA,
Li Hongpaul Yeh, PhD,
Ligia M Cline,
Ligia M Sanders,
Lillian C Lopez,
Lilly O Barton,
Linda R Kuchenthal,
Linda S Shook,
Ling Yu L Liu,
Lisa H Nakagawa,
Lisa K Capron,
Lopez,
Lorenzo F Edwards,
Lori A Gioia,
Lourdes M Countee,
LT Mark A Chen, MPH,
Lucas B Leake,
Lynda L Perry, PhD,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Makini Cobourne Duval, PhD,
Marjorie D Santos,
Mark C Saale,
Mark E Baldwin,
Mark E Chan,
Marsha L Mccauley,
Mary C Acton,
Mary R Hole,
Matthew A Walburger,
Matthew C Watson,
Matthew J Gretkierewicz,
Mcgrewp,
Megan E Kulas,
Melkamu Getie Kebtie, PhD,
Michael D Garcia,
Michael S Call,
Michelle L Lopez,
Michelle L Tripp,
Mohsen Rajabi Abhari, FDA,
Myers,
Ngoc B Kelsch,
Ngoc T Le,
Nianna C Burns,
Nicola M Fenty Stewart,
Nicole Yuen,
Nora W Kabbara,
Orval D Mcintire,
Peter E Baker,
Phillip J Sample,
Phung,
Randall J Plunkett,
Randall P Zielinski,
Randy L Elsberry,
Raymond Souweha,
Rebecca T Davis,
Robert C Hoover,
Robert D Ogan,
Robert P Neligan,
Robles,
Rochelle A Rolnik,
Rocio Guzman Velazquez,
Ronald P Boyce,
Ruben C Ayala, PharmD,
Sajin Bae,
Sandra S Saniga,
Scott B Laufenberg,
Scott J Matsuda,
Sean P Desbrow,
Seema S Singh,
Stefanie R Cook,
Steve P Yost,
Steven M Galvez,
Stuart W Russell,
Sundy V Sedwick,
Susanne M Richardson, MS RAC,
Suzanne M Crotty,
Tamara L Alexander,
Thanh M Andrews,
Thao T Kwan,
Theressa B Smith,
Thomas N Adjabeng,
Thomas W Gordon,
Timothy C Grome,
Tomanik'e C Banks,
Torrance J Slayton,
Tracey L Harris,
Travelle D Mason,
Tristian E Strait,
Tuan D Tran,
Victoria Taylor,
Willemsj,
William J Foust,
Wr Bowman,
Xikui Chen (nmi), PhD,
Yen Tso Kuo,
Young M Choi, PhD,
Yumi J Hiramine
Gulshan R Anand's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2011 | FDA 483 | Prizm Medical Inc. - Form 483, 2011-06-17 |
| September, 2006 | EIR | Saputo Cheese USA, Inc. - EIR, 2006-09-25 |
| November, 2011 | FDA 483 | Microfit, Inc. - Form 483, 2011-11-09 |
| March, 2011 | FDA 483 | Ophthalmic Imaging Systems - Form 483, 2011-03-25 |
| December, 2012 | EIR | Five Star Dairy #2 - EIR, 2012-12-21 |
| October, 2008 | FDA 483 | Sunrise Medical (US) LLC - Form 483, 2008-10-30 |
| June, 2011 | FDA 483 | SALTER LABS - Form 483, 2011-06-13 |
| January, 2010 | FDA 483 | Scholten Surgical Instruments - Form 483, 2010-01-21 |
| May, 2010 | FDA 483 | Sunrise Medical (US) LLC - Form 483, 2010-05-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more